Kim Byung-Jang – CEO, Mega Medical – South Korea
The CEO of Mega Medical, a Korean medical equipment manufacturer specialized in the ENT area, discusses his firm’s recent expansion into the anti-obesity segment, their strategy for building a global…
Since its establishment in 1995, Mega medical Co., Ltd. has localized medical equipment for ear-note-and throat (ENT), and currently been ranked No. 1 in domestic market share. This company will make every effort not only to maintain No. 1 market share in domestic market but also to take the first position in overseas markets.
1997 Specialized ENT unit launch
1999 Patent acquisition for wall-type nebulizer
2005 Cell-Q, a new obesity treatment product development
2006 Wireless visual system is selected as (wireless visual system) the world best quality product
2007 Digital wireless visual system development
2008 Obesity treatment device solution, Nato irrigation development
2009 HD visual system Development
2010 technical development for ENT Microscope development
2011 LIPO carbon therapy development
2013 Obesity treatment complex device development
Through consistent overseas market development since the establishment, Mega medical Co., Ltd. have exported out products over 40 countries including Europe, Asia, China, and Middle-East, and worked for global network construction.
Contact Details
Domestic inquiries
domestic@megamedical.co.kr
Tel. 1588-4493 (02-3662-4493)
Fax. 02-3661-0120
For overseas clients
Inquiry about products and warranty
webmaster@megamedical.co.kr
Tel. +82-2-3662-4493
Fax. +82-2-3661-0120
Address
#2504, 2505, A Bldg, Woolim blue 9 Business Center, 583, Yangcheon-ro, Gangseo-gu, Seoul (ZIP 157-779)
The CEO of Mega Medical, a Korean medical equipment manufacturer specialized in the ENT area, discusses his firm’s recent expansion into the anti-obesity segment, their strategy for building a global…
Julien Samson, vice president and general manager of GSK Korea explains how GSK’s new global strategy is being delivered within the Korean affiliate. Mr Samson explains the focus areas for…
As the 3rd largest pharma region in Asia, Korea’s booming pharma industry owes much to its mass of family-run conglomerates known as Chaebol. It comes as no surprise to find tech…
Shingyu Bae, CEO of MDimune, explains how the company’s new exosome drug delivery system increases efficacy and reduces toxicity compared with other oncology products. He also discusses the potential and…
Dae Jung Kim, president of Daiichi Sankyo Korea provides an insight into the rationale behind the company’s focus on the cardiovascular therapeutic area in South Korea. Mr Kim also reveals…
Kyung Kook Lee, chairman of KMDIA, explains the association’s role in working with the medical devices industry to boost both the local market and to raise Korea’s profile as a…
Jung Hyun Yun lifts the lid on Biosolution’s new stem cell technology that could revolutionize the treatment of cartilage-related ailments, such as osteoarthritis. He also discusses the plans for global…
Antimicrobial resistance (AMR) is a global health concern that we are increasingly understanding the consequences of and pulling together to try and keep under control. Korea is one of the…
Paul Henry Huibers, president of Lilly Korea discusses Lilly’s strong double-digit growth following a challenging period of restructuring. Huibers offers his opinion on the pricing difficulties within the Korean market,…
The South Korean government has designated the promotion of artificial intelligence (AI)-based drug development and healthcare innovation as a national priority. This new policy aims to capitalise on Korea’s advanced…
Uloff Münster, general manager of Merck Biopharma Korea provides his insights into the Korean healthcare system. Dr Münster also discusses the drug pricing situation in Korea and the potential for…
Young Jack Lee, CEO of LSK Global PS, Korea’s largest local contract research organization (CRO) gives his insights on the evolution of the clinical research environment over the past four…
Yong-Ik Kim, president of Korea’s National Health Insurance Service (NHIS), provides an insight into the implementation of the upcoming MoonCare reforms, the government’s strategy to ensure the expansion of coverage…
See our Cookie Privacy Policy Here
